Medopharm Advanced Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Months 2 Days
About Medopharm Advanced Research
Medopharm Advanced Research Private Limited (MARPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 October 2024 ( four months 2 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Prakash Chordia and Hastimal Chordia serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72100TN2024PTC173806
-
Company No.
173806
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Oct 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Medopharm Advanced Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Chordia
|
Director | 01-Oct-2024 | Current |
|
Hastimal Chordia
|
Director | 01-Oct-2024 | Current |
Financial Performance of Medopharm Advanced Research.
Enhance accessibility to Medopharm Advanced Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medopharm Advanced Research?
Unlock access to Medopharm Advanced Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tablets Medopharm Private LimitedHastimal Chordia is a mutual person
-
Medopharm Life FoundationPrakash Chordia and Hastimal Chordia are mutual person
-
Go Aawesome Venturz LlpHastimal Chordia is a mutual person
-
Achord Aggro Private Limited
Hastimal Chordia is a mutual person
-
Glo Q Innovations Private Limited
Hastimal Chordia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medopharm Advanced Research?
Unlock and access historical data on people associated with Medopharm Advanced Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medopharm Advanced Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medopharm Advanced Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.